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Abstract 
A study was conducted between January, 2005 to December, 2006 to ascertain the prevalence of 
pulmonary tuberculosis among patients who attended chest clinics in some randomly selected 
hospitals, Clinics and Health Centers in Ebonyi State, Nigeria. Investigations were carried out 
using the two popular diagnostic criteria for pulmonary tuberculosis namely the specific Ziehl 
Neelsen (ZN) methods and chest X-ray. A total of 962 patients with clinical signs and symptoms 
of tuberculosis were studied. Out of this figure, 559 (58.1%) had pulmonary tuberculosis with 
1:1 male/female ratio. There was no significant difference between ZN sputum smear positive 
and chest x-ray in the diagnosis of pulmonary tuberculosis in the studied population at 95% 
confidence level. The possible reasons for the high prevalence of pulmonary tuberculosis may 
be attributed to increase in the incidence of HIV/AIDS, high rate of poverty, emergence of 
drug-resistant strains of Mycobacteria and to a lesser extent, smoking and diabetes. 
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INTRODUCTION 
Pulmonary tuberculosis (TB) is a 
common, deadly infectious disease 
caused by Mycobacteria, mainly 
Mycobacterium tuberculosis. Tuberculosis 
most commonly attacks the lungs but 
can also affect the central nervous 
system, the lymphatic system, the 
circulatory system, the genitourinary 
system, bones, joints and even the skin.  
Other Mycobacteria such as 
Mycobacterium bovis, Mycobacterium 
africanum, Mycobacterium canetti and 
Mycobacterium microti can also cause 
tuberculosis especially in individuals 
with defective immune systems [1, 2] 
Tuberculosis can develop after inhaling 
droplets sprayed into the air from a  
 
 
cough or sneeze by someone infected 
with M. tuberculosis. The risk of 
contracting TB however increases with 
frequency of contact with people who  
have the disease, with crowded or 
unsanitary living conditions and with 
poor nutrition[2]. Others at risk of 
contracting the  disease include 
intravenous drug abusers, medically 
under-served and low-income 
populations, and patients 
immunocompromised by conditions 
such as HIV/AIDS, and health care 
workers serving these high risk 
patients[3]. 
Initial infection of TB (known as 
primary pulmonary tuberculosis) 
occurs when Mycobacteria reach the 
pulmonary alveoli and invade and 
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replicate within alveolar macrophages 
[4]. This primary stage of the infection is 
usually asymptomatic and in most cases 
patients recover from the infection 
without further evidence of the disease 
[5]. However in a few number of cases, 
especially when the immune system 
does not successfully contain the 
primary infection, the latent or 
asymptomatic TB always progresses to 
the active case. Symptoms of active 
cases of TB include chest pain, coughing 
up blood (hemoptysis) and a 
productive, prolonged cough for more 
than three weeks. The symptoms could 
also be systemic and may include fever, 
chills, night sweats, appetite loss, 
weight loss, pallor and often, a 
tendency to fatigue easily [6]. If 
untreated, active TB disease kills more 
than half of its victims [7]. 
Over one third of the world’s 
population are carriers of the bacterium, 
with new infections occurring at a rate 
of one per second[6]. This increase in TB 
resurgence may be attributable to 
increase in HIV infection and neglect of 
TB control programs, poor 
environment, poor nutrition and the 
emergence of drug resistant strains of 
the Mycobacterium[8;9]. As a result of the 
above factors, which also have 
worsened treatment efforts, TB has now 
been declared a global health 
emergency by the World Health 
Organization [10]. 
Materials and methods 
Sampling  
A total of 962 patients with suspected 
cases of pulmonary tuberculosis who 
presented to different chest clinics in 
some randomly selected hospitals and 
clinics in Ebonyi State were used for 
this two-year study which spanned 
from January 2005 to December 2006. 
This included 648 males and 314 
females. The purpose of the study was 
fully explained to them by the medical 
officers and their informed consents 
obtained prior to the study as 




A combination of chest x-ray and ZN 
techniques was used to screen the 
patients after physical examinations 
were made to assess their general health 
status. Sputum samples were obtained 
from patients showing signs of 
prolonged coughing to investigate for 
the presence of Mycobacterium 
tuberculosis using the Zieehl–Neelson’s 
acid fast staining method as applied 
by[12]. In the process each sputum 
specimen was swirled in its neat screw 
– capped container and with the help of 
a wire loop, smeared at the middle of a 
clean glass slide. The smear was air-
dried, heat-fixed over the bunsen 
burner flame and flooded with strong 
carbol fuchsin solution with the 
application of gentle heat for five 
minutes, on a staining rack. The smear 
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was next washed with water and 
decolourized by covering with 3% acid 
– alcohol for 10 minutes. It was washed 
again with water and counter stained 
using Loeffler’s methylene blue solution 
for 30 seconds. The stained smear was 
allowed to air-dry and examined 
microscopically using oil immersion 
(x1000) objective. The acid – fast 
bacteria appeared as bright red 
coloured rods that stood out clearly 
against the blue background of 
methylene blue, indicating positive 
cases. A parallel chest x–ray test was 
run on the same patients. The chest x-
ray which involved the standard 
posterior – anterior view was used as an 
extra confirmatory test for tuberculosis 
as recommended by[13]. In the test, 
cavitary lesions in the upper lobe of the 
lungs or mediastinal lymphadenopathy 
accompanied by patchy irregular 
consolidations indicated active 
pulmonary TB cases. Inactive cases 
were observed as fibrocalcific scar 
within the lungs. 
Results  
The results (Table 1) showed that a total 
number of 559 (58%) out of the 962 were  
diagnosed as PTB in the study.  This is 
the sum of the occurrence in 2005 with 
260 cases (27%) and 2006 with 299 cases 
(31%). There was no significant 
difference (p> 0.05) between the rate of 
PTB occurrence in years 2005 and 2006. 
The results as seen in Table 2 also 
showed that 324 (34%) males and 235  
(24%) females tested positive for PTB. 
TABLE 1: DISTRIBUTION OF PULMONARY TUBERCULOSIS AMONG PATIENTS IN UBURU,                                                
EBONYI STATE. 
                  YEAR TOTAL 
SCREENED  
ACTIVE PTB INACTIVE PTB PERCENTAGE ACTIVE PTB 
                     2005 461 260 201 27 
                      2006 501 299 202 31 
                TOTAL 962 559 403 58 
 
TABLE 2: DISTRIBUTION OF PTB AMONGST PATIENTS ACCORDING TO AND SEX IN UBURU, 
EBONYI STATE. 
YEAR Males   Female 
2005 152 108 
2006 172 127 




In 2005, 260 (27%) active TB cases were 
diagnosed in the community under 
survey. The figure rose to 299 (31%) in 
2006. This represents an increase of 39 
(4%) showing that more people may 
have been exposed to the pre-disposing 
factors that lead to the observed 
increase in the incidence of the disease 
in a space of only one year ( Table 1). 
 
Similarly, 152 (27.2%) men were 
diagnosed as active TB cases in 2005 
while the number of women was 108 
(19.3%) showing a difference of 44 
(7.9%) more men than women 
diagnosed of the infection in the year. In 
2006, the number of men diagnosed  
rose significantly to 172 (30.8%) 
representing an increase of 6.2 in the 
diagnosis of men made in 2005 and 
2006, while that of women also increase 
to 127 (22.7%) similarly representing an 
increase of 8.1% in the diagnosis of 
women in 2005 and 2006. The difference 
between diagnosis made of women and 
men was observed to be 45 (8.1%) in the 
year (Table 2). 
 
Incidence of TB was indeed on a steady 
increase in Uburu with more men 
suffering from the ailment than women 
probably because they were known to 
indulge more in the pre-disposing  
 
 
factors to the infection than the latter. 
This observation has been corroborated 
by that made by the World Health 
Organization, who reported that the 
incidence of TB was on the increase 
worldwide with nearly 2 billion people, 
representing one-third of the World’s 
population suffering from the disease 14 
. In addition, the Centre for Disease 
Control and Prevention  15  reported 
that about 8 million people are added to 
this figure with about 2 million deaths 
resulting ailment annually.  
 
Some factors which have been 
implicated in the re-emergence and 
subsequent epidemics of TB cases all 
over the world were also observed to be 
responsible for the increase in the 
incidence of the disease in Uburu. These 
include increase in the incidence of 
HIV/AIDS; individuals with immune 
systems damaged by HIV/AIDS have a 
higher risk of developing active TB – 
either from new exposure to the disease 
or a reactivation of dormant 
Mycobacteria. With the destruction of the 
immune system, treatment will become 
more difficult with the result that the 
disease will become more resistant to 
therapy[10]. Furthermore, the rate of 
emergence of drug – resistant strains of 
Mycobacteria, was enhanced by 
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inadequate treatments through not 
taking the prescribed regimen 
appropriately, or using low quality 
medications [16;2]. Drug resistant 
Mycobacteria caused an increase of about 
20% in TB resistance to standard 
treatments and 2% resistant to second-
line drugs recorded between 2000 and 
2004[5]. In addition there was a high 
level of poverty observed among the 
people in Uburu which must have 
contributed to the high prevalence of TB 
in the area. Poverty has been reported 
to be a very important factor in disease 
progression and prevalence in 
developing countries especially Sub-
Saharan Africa where majority of the 
twenty countries of the world with the 
highest rates of TB cases are said to be 
located[10]. Finally[17] reported that in 
addition to other factors, smoking more 
than 20 sticks of cigarette every day 
could increase the risk of succumbing to 
TB infections, while[18] identified 
diabetes mellitus as the greatest 
predisposing risk factor to this disease 
that is growing in importance in 
developing countries. Similar factors 
may also have been responsible for the 
rising cases of TB noticed in Uburu. 
 
With the incidence of HIV/AIDS 
pandemic which was reported[19] to be 
highly prevalent in Nigeria still 
wreaking havoc on the health status of 
many individuals, the re-emergence of 
TB epidemics in addition may initiate 
calls for a declaration of a state of 
emergency in the health sector. 
Fortunately, the WHO has already 
declared the disease a global health 
emergency and has instituted several 
measures to assist developing countries 
to control the infection and spread of 
Mycobacteria. The Nigerian government 
on its part is complementing this effort 
through its adequate provision of 
preventive BCG vaccines for infant 
vaccination in various hospitals and 
health centers; and numerous radio, 
newspaper, and television 
advertisements, urging anyone with 
suspected signs and symptoms of the 
disease or who is positive for the HIV 
virus to report for immediate diagnosis 
for TB. Positive individuals would 
commence early treatments with 
antituberculous drugs distributed freely 
at government-owned hospitals, health 
centers and clinics. 
 
However, the persistence and upsurge 
in TB cases today despite this generosity 
from government, calls for stringent 
managerial policies to be instituted to 
handle cases and contain the epidemic 
before the greater population in this 
country falls victim to the infection. To 
this effect, efforts should be made to 
improve the standard of living of every 
 85 
Nigerian through adequate provision of 
basic and essential amenities such as 
potable water, good food and affordable 
housing. Also in any situation where a 
patient has been diagnosed as a TB case, 
adequate control measures should be 
instituted to break the chain of possible 
transmission of infection to others by 
isolating such a patient compulsorily in 
a health center or clinic where intensive 
care could be given. Antituberculous 
drugs administered to such a patient 
should be closely monitored to ensure 
strict compliance to prescriptions and 
duration of treatments and thus prevent 
any form of drug resistance developing 
as a result of treatment failures. 
Furthermore, since inactive TB cases 
could progress to active forms later in 
life, especially after a reactivating 
infection of HIV, it will only become 
reasonable to subject all inactive cases 
to appropriate treatment with 
antituberculous drugs. In addition, 
campaigns on the treatment, prevention 
and control of HIV/AIDS should be 
intensified. Government must create 
adequate awareness on the aetiology 
and epidemiology of TB infection, 
stressing the need for healthy living 
involving good feeding, clean 
environment and adequate housing. 
However, government should provide 
relevant health institutions with 
diagnostic equipment and materials to 
detect Mycobacteria. Trained 
environmental personnel should be 
posted to the Local Government Areas 
to monitor public compliance to laid-
down policies on control and early 
detection of any outbreaks of the 
disease. Finally adequate protection 
should be given to all medical 
personnel and healthcare providers 
who handle TB patients, through 
immunization, payment of adequate 
hazard allowances and training since 
their constant contact with these high 
risk patients is a danger, not only to 
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